NewLink Genetics (NLNK)

Add to Watchlists
Create an Alert
20.94 +1.39  +7.11% NASDAQ Apr 16, 3:26PM BATS Real time Currency in USD
View Full Chart
NLNK Price Chart
View All Events

NLNK Events

Date Type Description
Mar 11 Misc Q4 2013 NewLink Genetics Corp Earnings Conference Call
Mar 11 Earnings Q4 2013 NewLink Genetics Corp Earnings Results. Estimate: -0.37.
Nov 12 Earnings NewLink Genetics Corporation Reports Third Quarter 2013 Financial Results. Estimate: -0.32.
Aug 07 Earnings NewLink Genetics Corporation Reports Second Quarter 2013 Financial Results. Estimate: -0.33.
May 09 Misc AGM Event for NewLink Genetics Corp
May 06 Earnings NewLink Genetics Corporation Reports First Quarter 2013 Financial Results. Estimate: -0.28.
View All Performance Charts

NLNK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NewLink Genetics is up 85.80% over the last year vs S&P 500 Total Return up 22.28%, Actelion up 73.17%, and Alexion Pharmaceuticals up 53.46%.

Get Quote for

Pro Report PDF for NLNK

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NLNK Pro Report PDF
Advertisement

Pro Strategies Featuring NLNK

Did NewLink Genetics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

NLNK Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Iowa
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

NewLink Genetics Corp., is a biopharmaceutical company. It focuses on discovering, developing and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NLNK 20.94 +1.39 +7.11% 556.44M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.